{"count": 11, "results": [{"_id": "7346433", "pmid": 7346433, "title": "Treatment of glaucoma with atenolol eye drops.", "journal": "Indian J Ophthalmol", "authors": ["Dhir SP", "Sharma PL", "Jain IS"], "date": "1981-10-01T00:00:00Z", "meta_date_publication": "1981 Oct", "meta_volume": "29", "meta_issue": "3", "meta_pages": "229-33", "score": 50087.297, "text_hl": "Treatment of @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@ with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ eye drops.", "citations": {"NLM": "Dhir SP, Sharma PL, Jain IS. Treatment of glaucoma with atenolol eye drops. Indian J Ophthalmol. 1981 Oct;29(3):229-33. PMID: 7346433", "BibTeX": "@article{7346433, title={Treatment of glaucoma with atenolol eye drops.}, author={Dhir SP and Sharma PL and Jain IS}, journal={Indian J Ophthalmol}, volume={29}, number={3}, pages={229-33}}"}}, {"_id": "326303", "pmid": 326303, "title": "Atenolol eye drops in glaucoma: a double-masked, controlled study.", "journal": "Br J Ophthalmol", "authors": ["Phillips CI", "Gore SM", "Macdonald MJ", "Cullen PM"], "date": "1977-05-01T00:00:00Z", "doi": "10.1136/bjo.61.5.349", "meta_date_publication": "1977 May", "meta_volume": "61", "meta_issue": "5", "meta_pages": "349-53", "score": 50078.645, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ eye drops in @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@: a double-masked, controlled study.", "citations": {"NLM": "Phillips CI, Gore SM, Macdonald MJ, Cullen PM. Atenolol eye drops in glaucoma: a double-masked, controlled study. Br J Ophthalmol. 1977 May;61(5):349-53. PMID: 326303", "BibTeX": "@article{326303, title={Atenolol eye drops in glaucoma: a double-masked, controlled study.}, author={Phillips CI and Gore SM and Macdonald MJ and Cullen PM}, journal={Br J Ophthalmol}, volume={61}, number={5}, pages={349-53}}"}}, {"_id": "7398531", "pmid": 7398531, "title": "Atenolol 4% eyedrops in glaucoma simplex.", "journal": "Doc Ophthalmol", "authors": ["Sterk CC"], "date": "1980-04-15T00:00:00Z", "doi": "10.1007/BF00141458", "meta_date_publication": "1980 Apr 15", "meta_volume": "48", "meta_issue": "2", "meta_pages": "309-14", "score": 50070.87, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ 4% eyedrops in @DISEASE_Glaucoma_Open_Angle @DISEASE_MESH:D005902 @@@glaucoma simplex@@@.", "citations": {"NLM": "Sterk CC. Atenolol 4% eyedrops in glaucoma simplex. Doc Ophthalmol. 1980 Apr 15;48(2):309-14. PMID: 7398531", "BibTeX": "@article{7398531, title={Atenolol 4% eyedrops in glaucoma simplex.}, author={Sterk CC}, journal={Doc Ophthalmol}, volume={48}, number={2}, pages={309-14}}"}}, {"_id": "6351901", "pmid": 6351901, "title": "Comparison of ocular hypotensive effects of 3 dosages of oral atenolol.", "journal": "Br J Ophthalmol", "authors": ["Tutton MK", "Smith RJ"], "date": "1983-10-01T00:00:00Z", "doi": "10.1136/bjo.67.10.664", "meta_date_publication": "1983 Oct", "meta_volume": "67", "meta_issue": "10", "meta_pages": "664-7", "score": 50068.277, "text_hl": "Some @SPECIES_9606 @@@patients@@@ complained of tiredness during treatment periods. Oral @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ may be useful additional therapy for @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@.", "citations": {"NLM": "Tutton MK, Smith RJ. Comparison of ocular hypotensive effects of 3 dosages of oral atenolol. Br J Ophthalmol. 1983 Oct;67(10):664-7. PMID: 6351901", "BibTeX": "@article{6351901, title={Comparison of ocular hypotensive effects of 3 dosages of oral atenolol.}, author={Tutton MK and Smith RJ}, journal={Br J Ophthalmol}, volume={67}, number={10}, pages={664-7}}"}}, {"_id": "656355", "pmid": 656355, "title": "Long-term hypotensive effect of atenolol 4% eyedrops.", "journal": "Br J Ophthalmol", "authors": ["Brenkman RF"], "date": "1978-05-01T00:00:00Z", "doi": "10.1136/bjo.62.5.287", "meta_date_publication": "1978 May", "meta_volume": "62", "meta_issue": "5", "meta_pages": "287-91", "score": 50067.098, "text_hl": "The effect of long-term application of 4% @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ eye drops has been studied in @SPECIES_9606 @@@patients@@@ with either @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@ or @DISEASE_Ocular_Hypertension @DISEASE_MESH:D009798 @@@ocular hypertension@@@. ", "citations": {"NLM": "Brenkman RF. Long-term hypotensive effect of atenolol 4% eyedrops. Br J Ophthalmol. 1978 May;62(5):287-91. PMID: 656355", "BibTeX": "@article{656355, title={Long-term hypotensive effect of atenolol 4% eyedrops.}, author={Brenkman RF}, journal={Br J Ophthalmol}, volume={62}, number={5}, pages={287-91}}"}}, {"_id": "24694602", "pmid": 24694602, "title": "Potential use of niosomal hydrogel as an ocular delivery system for atenolol.", "journal": "Biol Pharm Bull", "authors": ["Abu Hashim II", "El-Dahan MS", "Yusif RM", "Abd-Elgawad AE", "Arima H"], "date": "2014-01-01T00:00:00Z", "doi": "10.1248/bpb.b13-00724", "meta_date_publication": "2014", "meta_volume": "37", "meta_issue": "4", "meta_pages": "541-51", "score": 50063.543, "text_hl": "The purpose of this study was to prepare and characterize an effective ocular niosomal hydrogel containing 0.5% (w/v) @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ which is @GENE_ADRB1 @GENE_153 @@@beta1 adrenoceptor@@@ blocker for treatment of @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@. ", "citations": {"NLM": "Abu Hashim II, El-Dahan MS, Yusif RM, Abd-Elgawad AE, Arima H. Potential use of niosomal hydrogel as an ocular delivery system for atenolol. Biol Pharm Bull. 2014;37(4):541-51. PMID: 24694602", "BibTeX": "@article{24694602, title={Potential use of niosomal hydrogel as an ocular delivery system for atenolol.}, author={Abu Hashim II and El-Dahan MS and Yusif RM and Abd-Elgawad AE and Arima H}, journal={Biol Pharm Bull}, volume={37}, number={4}, pages={541-51}}"}}, {"_id": "2700474", "pmid": 2700474, "title": "A clinical study of effect of oral atenolol on normal intraocular pressure and systemic blood pressure.", "journal": "Indian J Ophthalmol", "authors": ["Chauhan JK", "Mishra YC", "Khilnani K"], "date": "1989-10-01T00:00:00Z", "meta_date_publication": "1989 Oct-Dec", "meta_volume": "37", "meta_issue": "4", "meta_pages": "179-81", "score": 50062.5, "text_hl": "The IOP on @SPECIES_9606 @@@patients@@@ with systemic @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ will be reduced and stoppage of therapy may cause @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma damage@@@.", "citations": {"NLM": "Chauhan JK, Mishra YC, Khilnani K. A clinical study of effect of oral atenolol on normal intraocular pressure and systemic blood pressure. Indian J Ophthalmol. 1989 Oct-Dec;37(4):179-81. PMID: 2700474", "BibTeX": "@article{2700474, title={A clinical study of effect of oral atenolol on normal intraocular pressure and systemic blood pressure.}, author={Chauhan JK and Mishra YC and Khilnani K}, journal={Indian J Ophthalmol}, volume={37}, number={4}, pages={179-81}}"}}, {"_id": "341739", "pmid": 341739, "title": "Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent.", "journal": "Albrecht Von Graefes Arch Klin Exp Ophthalmol", "authors": ["Ros FE", "Dake CL", "Offerhaus L", "Greve EL"], "date": "1977-12-31T00:00:00Z", "doi": "10.1007/BF00413464", "meta_date_publication": "1977 Dec 31", "meta_volume": "205", "meta_issue": "1", "meta_pages": "61-70", "score": 50062.12, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ 4% eye drops and @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@. ", "citations": {"NLM": "Ros FE, Dake CL, Offerhaus L, Greve EL. Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977 Dec 31;205(1):61-70. PMID: 341739", "BibTeX": "@article{341739, title={Atenolol 4% eye drops and glaucoma. A double-blind short-term clinical trial of a new beta1-adrenergic blocking agent.}, author={Ros FE and Dake CL and Offerhaus L and Greve EL}, journal={Albrecht Von Graefes Arch Klin Exp Ophthalmol}, volume={205}, number={1}, pages={61-70}}"}}, {"_id": "37605", "pmid": 37605, "title": "The beta-adrenergic blocking agents and the treatment of glaucoma.", "journal": "Surv Ophthalmol", "authors": ["Zimmerman TJ", "Boger WP 3rd"], "date": "1979-05-01T00:00:00Z", "doi": "10.1016/0039-6257(79)90228-5", "meta_date_publication": "1979 May-Jun", "meta_volume": "23", "meta_issue": "6", "meta_pages": "347-62", "score": 50057.832, "text_hl": "Autonomic agents used in the treatment of @DISEASE_Ocular_Hypertension @DISEASE_MESH:D009798 @@@ocular hypertension@@@ and @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@ include @CHEMICAL_Pilocarpine @CHEMICAL_MESH:D010862 @@@pilocarpine@@@, a chilinergic agonist, @CHEMICAL_Epinephrine @CHEMICAL_MESH:D004837 @@@epinephrine@@@, an adrenergic agonist, and various beta adrenergic blockers or antagonists including @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Timolol @CHEMICAL_MESH:D013999 @@@timolol@@@. ", "citations": {"NLM": "Zimmerman TJ, Boger WP 3rd. The beta-adrenergic blocking agents and the treatment of glaucoma. Surv Ophthalmol. 1979 May-Jun;23(6):347-62. PMID: 37605", "BibTeX": "@article{37605, title={The beta-adrenergic blocking agents and the treatment of glaucoma.}, author={Zimmerman TJ and Boger WP 3rd}, journal={Surv Ophthalmol}, volume={23}, number={6}, pages={347-62}}"}}, {"_id": "18179830", "pmid": 18179830, "title": "Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas).", "journal": "Aquat Toxicol", "authors": ["Winter MJ", "Lillicrap AD", "Caunter JE", "Schaffner C", "Alder AC", "Ramil M", "Ternes TA", "Giltrow E", "Sumpter JP", "Hutchinson TH"], "date": "2008-02-18T00:00:00Z", "doi": "10.1016/j.aquatox.2007.11.017", "meta_date_publication": "2008 Feb 18", "meta_volume": "86", "meta_issue": "3", "meta_pages": "361-9", "score": 50051.46, "text_hl": "...@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ is a beta-adrenergic receptor antagonist ('beta-blocker') widely used for the treatment of @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina@@@, @<m>DISEASE_Glaucoma</m> @DISEASE_MESH:D005901 @@@glaucoma@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@high blood pressure@@@ and other related conditions. ", "citations": {"NLM": "Winter MJ, Lillicrap AD, Caunter JE, Schaffner C, Alder AC, Ramil M, Ternes TA, Giltrow E, Sumpter JP, Hutchinson TH. Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat Toxicol. 2008 Feb 18;86(3):361-9. PMID: 18179830", "BibTeX": "@article{18179830, title={Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas).}, author={Winter MJ and Lillicrap AD and Caunter JE and Schaffner C and Alder AC and Ramil M and Ternes TA and Giltrow E and Sumpter JP and Hutchinson TH}, journal={Aquat Toxicol}, volume={86}, number={3}, pages={361-9}}"}}]}